The market for sleep apnea devices is expected to grow from $4.59 billion to $6.7 billion over the next 5 years, with the fastest-growing therapeutic device being oral appliances, according to a Markets and Markets report titled "Sleep Apnea Devices by Product, Therapeutic (CPAP, APAP, BPAP, Masks, Oral Appliances (Mandibular Advancement Device), Diagnostic (PSG, Pulse Oximeter), End User (Home Care Settings, Hospitals) - Analysis & Global Forecasts to 2021" that analyzes and studies the major market drivers, restraints/challenges, and opportunities.
This market, the report says, is expected to reach $6.7 billion by 2021, growing at a CAGR of 7.8% from the 2016 number of $4.59 billion.
The market is segmented into therapeutic devices and diagnostic devices, and therapeutic devices are further segmented into several categories, of which oral appliances are projected to register the highest CAGR in the forecast period.
The full report is available here: https://www.marketsandmarkets.com/pdfdownload.asp?id=719&utm_source=email-9-jan&utm_campaign=nl&utm_medium=md-na&utm_term=nl
